S&P Futures
3,857.50 +9.25 (+0.24%) Dow Futures
31,088.00 +75.00 (+0.24%) Nasdaq Futures
11,926.25 +46.00 (+0.39%) Russell 2000 Futures
1,734.10 +5.50 (+0.32%) Crude Oil
98.37 -0.16 (-0.16%) Gold
1,739.50 +3.00 (+0.17%)
BioLife Solutions, Inc. (BLFS)
After hours:
Chart Events
Performance Outlook
| Previous Close | 16.36 |
| Open | 16.08 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's Range | 16.08 - 16.62 |
| 52 Week Range | 10.40 - 60.67 |
| Volume | |
| Avg. Volume | 504,541 |
| Market Cap | 678.428M |
| Beta (5Y Monthly) | 1.75 |
| PE Ratio (TTM) | 124.35 |
| EPS (TTM) | 0.13 |
| Earnings Date | Mar 21, 2022 - Mar 25, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 38.88 |
- PR Newswire
BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced that its SciSafe® biostorage services platform will now offer a fleet of refrigerated and ultra-low temperature ("ULT") truck trailers to manage local cold chain movements for customers' biologic materials. This fleet provides an ideal transportation solution for any biologic product movement requiring
- Simply Wall St.
Investing in BioLife Solutions (NASDAQ:BLFS) five years ago would have delivered you a 496% gain
The last three months have been tough on BioLife Solutions, Inc. ( NASDAQ:BLFS ) shareholders, who have seen the share...
- Zacks
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Lags Revenue Estimates
BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 29.17% and 4.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
